AzTrials
AzTrials

Alcohol Use DisorderNCT03396887

The Effectiveness of a Smartphone Application in the Treatment of Alcohol Use Disorder

A study of Alcohol Use Disorder, run by St Patrick's Hospital, Ireland at 1 site in Ireland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Alcohol dependence poses a major problem for Irish and UK society, placing a huge burden on the health system. It is difficult to treat and relapse is common. There is an urgent need to develop novel treatment methods. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Alcohol Use Disorder
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteIreland
Study dates
1 May 2017to 30 Sep 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients will fulfil the criteria for an alcohol use disorder according to the Structured Clinical Interview for DSM-5 Axis I Disorders
  • Patients must complete an alcohol treatment programme at St. Patrick's University Hospital.
  • Primary addiction must be alcohol in poly-substance abusers.
  • Aged over 18 years of age and capable of providing written, informed consent.
  • Mini Mental State Examination (MSSE) score of ≥25.
  • Patients must have an iphone or Android smartphone and are familiar with using smartphone applications.

Who cannot join

  • Patients whose primary substance of abuse is not alcohol, although may meet the criteria for alcohol dependency/abuse.
  • Patients who do not have an iPhone or Android smartphone.
  • Age <18years or >70years.
  • Psychotic disorder
  • Patients who do not fully complete an inpatient treatment programme before discharge.
  • History of alcohol use disorder but not current.

Trial locations and contacts

1 site in 1 country.

Conor Farren, PhD,MRCPsych contact

+35312493523

cfarren@stpatsmail.com

Ireland1 site, 1 recruiting
  • St. Patrick's University Hospital

    Dublin, Dublin 8

    Conor Farren, PhD MRCPsych, +35312493523, cfarren@stpatsmail.com

    Recruiting

Other trials in Ireland

About this study

Alcohol dependence poses a major problem for Irish and UK society, placing a huge burden on the health system. It is difficult to treat and relapse is common. There is an urgent need to develop novel treatment methods. One growing area of intervention is the use of mobile phone technology to develop personalised, patient-centred treatments. These can be used in outpatient settings, allowing patients to manage their own illness and take control of their recovery. In this study the investigators will investigate how a smartphone application, UControlDrink, can help alcoholics stay abstinent from alcohol. The application consists of a number of features known to aid recovery such as supportive messages and online therapy.

Read the detailed description

Alcohol use disorder (AUD) is a common and difficult disorder to treat. Only a fraction of sufferers seek treatment and the rate of relapse is high. There is therefore an urgent need for improved methods of promoting long term abstinence and recovery in AUD. This study will explore the effectiveness of a smartphone application, UControlDrink, in aiding recovery from AUD in patients who have been discharged from an inpatient alcohol treatment programme. The application comprises five recovery focused features:

supportive messages, Computerised-Cognitive Behavioural Therapy, a drinking log, activities and trigger avoidance log, craving management and gamification. Patients will use the application for 3 months. A control group of patients will also be followed over the same time period. Cumulative abstinence duration as well as changes in questionnaire measures to baseline, time to first drink, proportion of patients continuously abstinent from alcohol, levels of activity within the app and patient satisfaction with their overall treatment will be measured at 3 months. If successful, this application may offer a unique, patient-centred, technology-driven, cost effective method of improving outcomes in AUD.

Being tested
U Control Drink Smartphone Application, Control group
Keywords
Alcohol Use Disorder, Smartphone Application
Medical subject headings
Alcoholism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • U Control Drink Smartphone ApplicationOther

    The smartphone application comprises five recovery focused features: supportive messages, Computerised-Cognitive Behavioural Therapy, a drinking log, craving management and gamification.

  • Control groupOther

    The control group will receive treatment as usual.

Study groups in NCT03396887
Study groupRoleWhat they receive
Smartphone Application UsersExperimentalThe experimental group will receive the smartphone intervention along with treatment as usual for 3-months. The smartphone application (UControlDrink) includes twice daily text message recovery support, relapse prevention cognitive behavioural therapy, 12 sessions in total, drinking and recovery activity logs where participants detail their abstinence, drinking and recovery activity engagement on a daily basis. Craving intervention in the form of a "calm button" to deal with cravings and prevent relapse and gamification, a system of encouraging positive behaviour with the awarding of "points" to achieve various "status" levels, is used to increase adherence and compliance with treatment recommendations.
Receives: Other: U Control Drink Smartphone Application
Control GroupActive comparatorThe control group will also receive treatment as usual, i.e. any follow-up after-care that they chose to participate in and regular AA/Lifering meetings.
Receives: Other: Control group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of drinking days

    The number of drinking days will be assessed using the Time Line to Follow-Back scale (TLFB).The Alcohol TLFB is a descriptive questionnaire, using a calendar, participants will retrospectively record the number of days they drank over the previous 90 days. Drinking days will be calculated by summing the total number of days when alcohol was consumed in the previous 90 days.

    Measured: 3 months

  2. App activity score

    Activity score on the app

    Measured: 3 months

  3. Units of alcohol consumed per drinking day

    The Time Line Follow Back (TLFB) will be used to record the average number of units of alcohol consumed on drinking days.

    Measured: 3 months

Secondary outcomes (6)
  1. Time to first drink

    Number of days to first drink

    Measured: 3 months

  2. Changes in the Alcohol Use Disorders Identification Test scores from baseline

    Changes in scores on the Alcohol Use Disorders Identification Test between baseline and 3 month follow-up assessment.

    Measured: 3 months

  3. Changes in the Alcohol Abstinence Self-Efficacy Scale scores from baseline

    Changes in the Alcohol Abstinence Self-Efficacy Scale scores between baseline and 3 month follow-up assessment.

    Measured: 3 months

  4. Changes in the Obsessive Compulsive Drinking Scale scores from baseline

    Changes in scores on the Obsessive Compulsive Drinking Scale between baseline and 3 month follow-up assessment.

    Measured: 3 months

  5. Changes in the Beck Depression Inventory scores from baseline

    Changes in scores on the Beck Depression Inventory between baseline and 3 month follow-up assessment.

    Measured: 3 months

  6. Changes in the Beck Anxiety Inventory scores from baseline

    Changes in scores on the Beck Anxiety Inventory between baseline and 3 month follow-up assessment.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jan 2018
  2. Study start1 May 2017
  3. Primary completion31 Jul 2018 (estimated)
  4. Study completion30 Sep 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomised to intervention or control condition.
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03396887
Sponsor's protocol ID
UCD - Protocol 19/15
Status last verified
Nov 2017
First submitted
12 May 2017
Last updated
11 Jan 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study of Alcohol Use Disorder, run by St Patrick's Hospital, Ireland at 1 site in Ireland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Ireland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Conor Farren, PhD,MRCPsych (+35312493523, cfarren@stpatsmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of drinking days (time frame: 3 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jan 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in